Linking Hospitalized Injection Drug Users to Buprenorphine
|ClinicalTrials.gov Identifier: NCT00987961|
Recruitment Status : Completed
First Posted : October 1, 2009
Last Update Posted : November 11, 2015
|Condition or disease||Intervention/treatment||Phase|
|Opiate Dependence||Behavioral: Linkage||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||147 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Linking Hospitalized Injection Drug Users to Buprenorphine|
|Study Start Date :||September 2009|
|Actual Primary Completion Date :||March 2014|
|Actual Study Completion Date :||September 2015|
No Intervention: Treatment as usual
Participants in this arm will receive the standard detox treatment for individuals hospitalized with opioid dependence.
Participants in this arm will receive a maintenance schedule of Suboxone during their hospital stay, and an appointment with an outpatient Suboxone provider for after their discharge.
This intervention provides an outpatient appointment with a Suboxone provider for medically hospitalized opioid-dependent patients to attend post-discharge.
- opioid use [ Time Frame: baseline, 1-month, 3-months, 6-months ]
- HIV risk behavior [ Time Frame: baseline, 1-month, 3-months, 6-months ]
- reduction in injection-related medical conditions [ Time Frame: baseline, 1-month, 3-months, 6-months ]
- reduction in emergency department and hospital utilization [ Time Frame: baseline, 1-month, 3-months, 6-months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00987961
|United States, Massachusetts|
|Boston Medical Center|
|Boston, Massachusetts, United States, 02118|
|Principal Investigator:||Michael D Stein, MD||Butler Hospital|